PREOB
-
Biologics
Bone Therapeutics SA and Asahi Kasei sign exclusive license agreement for PREOB® in Japan
Gosselies, Belgium, 22 September 2017, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing…
Read More » -
Biologics
Bone Therapeutics Reports Initial Efficacy Results from Its PREOB® Phase IIA Trial in Severe Osteoporosis
BONE THERAPEUTICS (Brussels:BOTHE) (Paris:BOTHE) (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in…
Read More » -
Recon
Bone Therapeutics Reports First Results of Its Phase IIA Trial for PREOB® in Severe Osteoporosis
BONE THERAPEUTICS (Brussels:BOTHE) (Paris:BOTHE) (Euronext Brussels and Paris: BOTHE) the bone cell therapy company addressing high unmet medical needs in the field of…
Read More »